Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SGN1 |
Synonyms | |
Therapy Description |
SGN1 is a strain of Salmonella enterica engineered to harbor mutations in the MSBB and PURI genes and to express L-methioninase, which potentially reduces tumor methionine levels and inhibits umor growth (PMID: 36077761, NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SGN1 | SGN-1|SGN 1|SalMet-Vec | SGN1 is a strain of Salmonella enterica engineered to harbor mutations in the MSBB and PURI genes and to express L-methioninase, which potentially reduces tumor methionine levels and inhibits umor growth (PMID: 36077761, NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05103345 | Phase I | SGN1 | Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor | Recruiting | 2 | |
NCT05038150 | Phase I | SGN1 | Study of SGN1 in Patients With Advanced Solid Tumor | Recruiting | USA | 1 |